Health outcomes attributable to carbapenemase-producing Enterobacteriaceae infections: A systematic review and meta-analysis

被引:22
|
作者
Budhram, Dalton R. [1 ]
Mac, Stephen [2 ,3 ]
Bielecki, Joanna M. [3 ]
Patel, Samir N. [4 ,5 ]
Sander, Beate [2 ,3 ,4 ,6 ]
机构
[1] Queens Univ, Dept Med, Kingston, ON, Canada
[2] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[3] Univ Hlth Network, Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada
[4] Publ Hlth Ontario, Publ Hlth Ontario Lab, 661 Univ Ave, Toronto, ON, Canada
[5] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[6] Inst Clin Evaluat Sci, Toronto, ON, Canada
关键词
CARE-UNIT PATIENTS; KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; RESISTANT ENTEROBACTERIACEAE; BETA-LACTAMASE; MORTALITY; IMPACT; COLONIZATION;
D O I
10.1017/ice.2019.282
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Carbapenemase-producing Enterobacteriaceae (CPE) pose a significant global health threat. Objective: To conduct a systematic review of health outcomes and long-term sequelae attributable to CPE infection. Methods: We followed PRISMA reporting guidelines and published our review protocol on PROSPERO (CRD42018097357). We searched Medline, Embase, CINAHL and the Cochrane Library. We included primary studies with a carbapenem-susceptible control group in high-income countries, published in English. Quality appraisal was completed using Joanna Briggs Institute checklists. We qualitatively summarized frequently reported outcomes and conducted a meta-analysis. Results: Our systematic review identified 8,671 studies; 17 met the eligibility criteria for inclusion. All studies reported health outcomes; none reported health-related quality-of-life. Most studies were from Europe (65%), were conducted in teaching or university-affiliated hospitals (76%), and used case-control designs (53%). Mortality was the most commonly reported consequence of CPE-infections; in-hospital mortality was most often reported (62%). Our meta-analysis (n = 5 studies) estimated an absolute risk difference (ARD) for in-hospital bloodstream infection mortality of 0.25 (95% confidence interval [CI], 0.17-0.32). Duration of antibiotic therapy (range, 4-29.7 vs 1-23.6 days) and length of hospital stay (range, 21-87 vs 15-43 days) were relatively higher for CPE-infected patients than for patients infected with carbapenem-susceptible pathogens. Most studies (82%) met >80% of their respective quality appraisal criteria. Conclusions: The risk of in-hospital mortality due to CPE bloodstream infection is considerably greater than carbapenem-susceptible bloodstream infection (ARD, 0.25; 95% CI, 0.17-0.32). Health outcome studies associated with CPE infection are focused on short-term (eg, in-hospital) outcomes; long-term sequelae and quality-of-life are not well studied.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 50 条
  • [1] Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis Mortality due to KPC Klebsiella pneumoniae infections
    Ramos-Castaneda, Jorge A.
    Ruano-Ravina, Alberto
    Barbosa-Lorenzo, Raquel
    Paillier-Gonzalez, Jaime E.
    Saldana-Campos, Javier C.
    Salinas, Diego F.
    Lemos-Luengas, Elkin V.
    JOURNAL OF INFECTION, 2018, 76 (05) : 438 - 448
  • [2] Prevalence of carbapenemase-producing Enterobacteriaceae from human clinical samples in Ethiopia: a systematic review and meta-analysis
    Alemayehu, Ermiyas
    Fiseha, Temesgen
    Gedefie, Alemu
    Alemayehu Tesfaye, Nuhamin
    Ebrahim, Hussen
    Ebrahim, Endris
    Fiseha, Mesfin
    Bisetegn, Habtye
    Mohammed, Ousman
    Tilahun, Mihret
    Gebretsadik, Daniel
    Debash, Habtu
    Gobezie, Mengistie Yirsaw
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [3] Treating infections caused by carbapenemase-producing Enterobacteriaceae
    Tzouvelekis, L. S.
    Markogiannakis, A.
    Piperaki, E.
    Souli, M.
    Daikos, G. L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (09) : 862 - 872
  • [4] Evaluation of the Therapeutic Outcomes of Antibiotic Regimen Against Carbapenemase-Producing Klebsiella pneumoniae: A Systematic Review and Meta-Analysis
    Effah, Clement Yaw
    Drokow, Emmanuel Kwateng
    Agboyibor, Clement
    Liu, Shaohua
    Nuamah, Emmanuel
    Sun, Tongwen
    Miao, Lijun
    Wang, Jing
    Xu, Zhiwei
    Wu, Yongjun
    Zhang, Xiaoju
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [5] Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia
    Tamma, Pranita D.
    Goodman, Katherine E.
    Harris, Anthony D.
    Tekle, Tsigereda
    Roberts, Ava
    Taiwo, Abimbola
    Simner, Patricia J.
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (03) : 257 - 264
  • [6] Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review
    Kopotsa, Katlego
    Sekyere, John Osei
    Mbelle, Nontombi Marylucy
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2019, 1457 (01) : 61 - 91
  • [7] Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-Analysis
    Flokas, Myrto Eleni
    Karanika, Styliani
    Alevizakos, Michail
    Mylonakis, Eleftherios
    PLOS ONE, 2017, 12 (01):
  • [8] Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta-analysis
    Alevizakos, Michail
    Nasioudis, Dimitrios
    Mylonakis, Eleftherios
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (06)
  • [9] A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
    Gutierrez-Gutierrez, Belen
    Salamanca, Elena
    de Cueto, Marina
    Hsueh, Po-Ren
    Viale, Pierluigi
    Ramon Pano-Pardo, Jose
    Venditti, Mario
    Tumbarello, Mario
    Daikos, George
    Pintado, Vicente
    Doi, Yohei
    Francisco Tuon, Felipe
    Karaiskos, Ilias
    Machuca, Isabel
    Schwaber, Mitchell J.
    Azap, Ozlem Kurt
    Souli, Maria
    Roilides, Emmanuel
    Pournaras, Spyros
    Akova, Murat
    Perez, Federico
    Bermejo, Joaquin
    Oliver, Antonio
    Almela, Manel
    Lowman, Warren
    Almirante, Benito
    Bonomo, Robert A.
    Carmeli, Yehuda
    Paterson, David L.
    Pascual, Alvaro
    Rodriguez-Bano, Jesus
    MAYO CLINIC PROCEEDINGS, 2016, 91 (10) : 1362 - 1371
  • [10] Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysis
    Flokas, Myrto Eleni
    Detsis, Marios
    Alevizakos, Michail
    Mylonakis, Eleftherios
    JOURNAL OF INFECTION, 2016, 73 (06) : 547 - 557